Patents by Inventor Regina M. Reilly

Regina M. Reilly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-SEZ6 ANTIBODY DRUG CONJUGATES
    Publication number: 20240091374
    Abstract: The present disclosure provides SEZ6 antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
    Type: Application
    Filed: August 25, 2023
    Publication date: March 21, 2024
    Inventors: Emily Jean Faivre, Andrew C. Phillips, Regina M. Reilly, Eoghainin O'hainmhire
  • ANTI-C-MET ANTIBODY DRUG CONJUGATES
    Publication number: 20230372519
    Abstract: The present disclosure provides c-Met antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
    Type: Application
    Filed: March 9, 2023
    Publication date: November 23, 2023
    Applicant: AbbVie Inc.
    Inventors: Andrew C. Phillips, Regina M. Reilly, George A. Doherty, Cheng Ji, Milan Bruncko, Erwin R. Boghaert, Mark Anderson
  • Anti-c-Met antibody drug conjugates
    Patent number: 11633497
    Abstract: The present disclosure provides c-Met antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
    Type: Grant
    Filed: April 29, 2022
    Date of Patent: April 25, 2023
    Assignee: AbbVie Inc.
    Inventors: Andrew C. Phillips, Regina M. Reilly, George A. Doherty, Cheng Ji, Milan Bruncko, Erwin R. Boghaert, Mark Anderson
  • ANTI-C-MET ANTIBODY DRUG CONJUGATES
    Publication number: 20220378935
    Abstract: The present disclosure provides c-Met antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
    Type: Application
    Filed: April 29, 2022
    Publication date: December 1, 2022
    Inventors: Andrew C. PHILLIPS, Regina M. REILLY, George A. DOHERTY, Cheng JI, Milan BRUNCKO, Erwin R. BOGHAERT, Mark ANDERSON
  • Repeated Dosing of TRPV1 Antagonists
    Publication number: 20100210682
    Abstract: Disclosed herein are methods for increasing analgesic potency of TRPV1 antagonists, said methods comprise of repeated administration of the TRPV1 antagonists in a subject. Methods for treating or preventing pain by repeated administration of a TRPV1 antagonist are also discussed.
    Type: Application
    Filed: February 19, 2010
    Publication date: August 19, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Connie R. Faltynek, Arthur R. Gomtsyan, Marie P. Honore, Michael F. Jarvis, Shailen K. Joshi, Michael E. Kort, Philip R. Kym, Torben R. Neelands, Regina M. Reilly, Carol S. Surowy